Roivant Sciences ROIV
NASDAQ ROIV
$41.43 -0.05 (-0.12%)
As of: Sep 9, 2026 · 11:14 AM EDT

Roivant Sciences (ROIV) Current Taxes (2022 - 2026)

Roivant Sciences' (ROIV) quarterly Current Taxes came in at $74.2 million in Q2 2026, up 62.36% quarter-over-quarter from $45.7 million in Q1 2026.

Analysis

Roivant Sciences (ROIV) Current Taxes (2022 - 2026) Analysis & Trends

Roivant Sciences (ROIV) has reported Current Taxes for 5 consecutive years, with $74.2 million the latest figure, recorded in Q2 2026.

  • For the quarter ending Q2 2026, Current Taxes changed N/A year-over-year to $74.2 million; the trailing twelve-month figure through Jun 2026 stood at $74.2 million (changed N/A YoY), and the FY2026 full-year result was $45.7 million, up 10882.93% from the prior year.
  • Current Taxes climbed to $74.2 million in Q2 2026 per ROIV's latest filing, from $45.7 million in the prior quarter.
  • Across five years, Current Taxes topped out at $74.2 million in Q2 2026 and bottomed at $416000.0 in Q1 2025.
  • Historically, Current Taxes has averaged $14.9 million across 5 years, with a median of $5.4 million in 2024.
  • The sharpest annual moves came in 2024 and 2026: Current Taxes sank 97.72% in 2024, then surged 10882.93% in 2026.
  • Over 5 years, Current Taxes stood at $5.6 million in 2022, then soared by 347.45% to $25.2 million in 2023, then tumbled by 97.72% to $576000.0 in 2024, then dropped by 27.78% to $416000.0 in 2025, then surged by 17732.21% to $74.2 million in 2026.
  • According to Business Quant data, Current Taxes over the past three periods registered $74.2 million, $45.7 million, and $416000.0 for Q2 2026, Q1 2026, and Q1 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Taxes (Qtr)
1 Amgen 211.68 Bn 197.69 Bn 7.24 Bn -
2 Gilead Sciences 180.84 Bn 177.66 Bn 6.22 Bn -
3 Vertex Pharmaceuticals 132.30 Bn 124.45 Bn 2.84 Bn -
4 Regeneron Pharmaceuticals 82.50 Bn 74.50 Bn 3.93 Bn -
5 Argenx Se 61.49 Bn 56.31 Bn 1.37 Bn 49.00 Mn
6 Moderna 55.01 Bn 49.87 Bn 52.00 Mn -
7 Alnylam Pharmaceuticals 34.08 Bn 30.77 Bn 992.69 Mn -
8 Biogen 31.35 Bn 30.06 Bn 1.96 Bn 86.90 Mn
9 Roivant Sciences 29.87 Bn 29.87 Bn 1.16 Mn 74.18 Mn
10 Insmed 27.84 Bn 26.68 Bn 358.27 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 74.18 Mn
Mar 31, 2026 45.69 Mn
Mar 31, 2025 416,000.00
Dec 31, 2024 576,000.00
Sep 30, 2024 5.41 Mn
Jun 30, 2024 23.44 Mn
Mar 31, 2024 9.77 Mn
Dec 31, 2023 25.22 Mn
Sep 30, 2023 1.36 Mn
Jun 30, 2023 1.24 Mn
Mar 31, 2023 542,000.00
Dec 31, 2022 5.64 Mn
Mar 31, 2022 708,000.00